Gene Therapy and Sickle Cell Disease
What Should Patients Know About Current Gene Therapy Treatments?
Knowing About Participating in Clinical Trials - FAQs
Source: National Institutes of Health Year: 2017Learn About Genome Editing for Sickle Cell Disease
Source: National Heart, Lung, and Blood Institute (NHLBI) Year: 2020Statement on NHLBI Decision to Pause the Pilot and Feasibility Study of Hematopoietic Stem Cell Gene Transfer for Sickle Cell Disease
Source: National Heart, Lung, and Blood Institute (NHLBI) Year: 2021Better Education Needed to Give Patients Improved Understanding of Gene Therapies, New Review Highlights
Source: University of Birmingham Year: 20205 Things to Know About CRISPR and Gene Editing in the COVID Era
Source: World Economic Forum Year: 2020Gene Therapy ARU-1801 Showing Early Efficacy, Safety in Phase 1/2 Trial
Source: BioNews, Inc. Year: 2021To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.